welcomes you to the new, improved website!The authors conducted a retrospective cohort study of 88 patients that received methylene blue (MB) for refractory vasoplegia following cardiopulmonary bypass. Administration of MB was associated with an 8 mmHg increase in mean arterial pressure, with the peak response occurring at 2 hours after completion of dose.
You are here:
Methylene blue for postcardiopulmonary bypass vasoplegic syndrome: A cohort study
Submitted by: Arie Blitz
Source: Annals of Cardiac Anesthesia
Keywords:
Author(s): Michael Mazzeffi1, Benjamin Hammer2, Edward Chen3, Mark Caridi-Scheible4, James Ramsay5, Christopher Paciullo6
